Form 8-K - Current report:
SEC Accession No. 0001108205-25-000022
Filing Date
2025-03-28
Accepted
2025-03-28 08:16:31
Documents
22
Period of Report
2025-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-20250328.htm   iXBRL 8-K 71496
2 EX-4.1 ex41formofpre-fundedwarrant.htm EX-4.1 122601
3 EX-4.2 ex42-formofcommonstockwarr.htm EX-4.2 123270
4 EX-5.1 curis-exhibit51opinion.htm EX-5.1 11848
5 EX-10.1 ex101-securitiespurchaseag.htm EX-10.1 248500
6 EX-10.2 ex102-registrationrightsag.htm EX-10.2 115908
7 EX-99.1 ex991unauditedfinancialinf.htm EX-99.1 36952
11 image.jpg GRAPHIC 9445
12 image1.jpg GRAPHIC 3047
13 image_2.jpg GRAPHIC 38658
  Complete submission text file 0001108205-25-000022.txt   1072711

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20250328.xsd EX-101.SCH 1789
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20250328_lab.xml EX-101.LAB 22548
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20250328_pre.xml EX-101.PRE 13054
24 EXTRACTED XBRL INSTANCE DOCUMENT cris-20250328_htm.xml XML 2821
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 25781562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)